41 – 50 of 256
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Register data on long-term morbidity after prostate cancer radiotherapy with ultra-hypofractionated (2.5 weeks) vs conventional (8 weeks) treatment schedules
2024) U21 Health Sciences Group 2024 Doctoral Student Forum(
- Contribution to conference › Poster
-
Mark
Anti-Müllerian hormone and fertility in women after childhood cancer treatment : Association with current infertility risk classifications
(
- Contribution to journal › Article
-
Mark
In vivo dendritic cell reprogramming for cancer immunotherapy
(
- Contribution to journal › Article
-
Mark
Effects of Recombinant α1-Microglobulin on Early Proteomic Response in Risk Organs after Exposure to 177Lu-Octreotate
(
- Contribution to journal › Article
-
Mark
Impact of site-specific conjugation strategies on the pharmacokinetics of antibody conjugated radiotherapeutics
(
- Contribution to journal › Article
-
Mark
Author Reply
(
- Contribution to journal › Letter
-
Mark
Intratumoral Distribution of [177Lu]Lu-PSMA-617 Over Time and in Relation to Diagnostic Tracers in Animal Models of Prostate Cancer
2024) In Cancer Biotherapy and Radiopharmaceuticals(
- Contribution to journal › Article
-
Mark
Behandling av icke spridd prostatacancer – individuellt val
(
- Contribution to journal › Article
-
Mark
Feasibility and constraints of Bragg peak FLASH proton therapy treatment planning
(
- Contribution to journal › Article
-
Mark
Beyond Average : a-Particle Distribution and Dose Heterogeneity in Bone Metastatic Prostate Cancer
(
- Contribution to journal › Article